NCT01477918

Prevalence of Metabolic Syndrome in Patients With Schizophrenia in Korea

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 1,000 (estimated)
• Sponsor: Asan Medical Center · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to examine the prevalence of the Metabolic syndrome(MetS) in Korean patients with schizophrenia. Primary objective: • To investigate the prevalence of the MetS in Korean patients with schizophrenia Secondary objectives: • To compare the prevalence of the MetS among 3 groups according to antipsychotics: typical antipsychotic monotherapy group, atypical antipsychotic monotherapy group, 2 or more antipsychotics group (polypharmacy)

Conditions

• Schizophrenia
• Metabolic Syndrome

Timeline

• Start date: 2011-12-01
• First posted: 2011-11-23
• Last updated: 2011-11-23

Locations

1 site across 1 country: South Korea